LOADING
Comparing Merck & Company (MRK) and Walmart Inc (WMT) across the Health Care and Consumer Staples sectors. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | MRK | WMT |
|---|---|---|
| Price | -- | -- |
| Change Today | +0.00% | +0.00% |
| Market Cap | $307.2B | $881.0B |
| P/E Ratio | 36.0 | 39.0 |
| Forward P/E | 48.3 | 38.2 |
| PEG Ratio | 12.06 | 4.24 |
| EPS | $3.55 | $2.84 |
| Revenue Growth (YoY) | 4.9% | 7.3% |
| Profit Margin | 13.6% | 3.1% |
| Return on Equity | 18.9% | 24.1% |
| Dividend Yield | 2.52% | 0.86% |
| Beta | 0.21 | 0.60 |
| 52-Week High | $135.05 | $135.16 |
| 52-Week Low | $75.81 | $94.85 |
| Volume | -- | -- |
Walmart Inc is the larger company by market capitalization. Merck & Company trades at a lower P/E ratio, suggesting it may offer better value relative to earnings. Merck & Company offers a higher dividend yield for income investors. Merck & Company has stronger profit margins. Both stocks should be evaluated in the context of your investment goals, risk tolerance, and portfolio diversification needs.